Federal Act
on Medicinal Products and Medical Devices
(Therapeutic Products Act, TPA)

¹ For thera­peut­ic products which con­tain or con­sist of de­vi­tal­ised hu­man tis­sues or cells, or de­riv­at­ives there­of, the Fed­er­al Coun­cil shall spe­cify re­quire­ments for the dona­tion, re­mov­al, test­ing and de­vi­tal­isa­tion of these tis­sues or cells.

² It may make sub­ject to spe­cif­ic re­quire­ments of this Act and of the Trans­plant­a­tion Act of 8 Oc­to­ber 2004⁷ products which con­tain or con­sist of de­vi­tal­ised hu­man tis­sues or cells, or de­riv­at­ives there­of, and are not thera­peut­ic products, but func­tion as thera­peut­ic products. In ad­di­tion, it may also spe­cify re­quire­ments for the dona­tion, re­mov­al, test­ing and de­vi­tal­isa­tion of such tis­sues or cells, or de­riv­at­ives there­of.

³ Hu­man tis­sue or hu­man cells may only be re­moved or used for the man­u­fac­ture of products as spe­cified in para­graphs 1 and 2 if con­sent has been ob­tained for re­mov­al. For this tis­sue and these cells, neither fin­an­cial gain nor any oth­er ad­vant­age may be offered, gran­ted, de­man­ded or ac­cep­ted.